CervoMed Announces New Hire to Support Neflamapimod Development and Commercialization
Go back to CervoMed Announces New Hire to Support Neflamapimod Development and Commercialization| (NASDAQ: CRVO) | Delayed: 2.73 -0.2 (6.83%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.93 | 52 Week High | $ | |||
| Open | $2.99 | 52 Week Low | $ | |||
| Day High | $2.99 | P/E | N/A | |||
| Day Low | $2.68 | EPS | $ | |||
| Volume | 608,534 | |||||

